Identification of a novel cell-penetrating peptide from human phosphatidate phosphatase LPIN3

Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness

(2012) Je-Min Choi et al.   IMMUNOLOGY LETTERS

Protein transduction domain delivery of therapeutic macromolecules

(2011) Arjen van den Berg et al.   CURRENT OPINION IN BIOTECHNOLOGY

Subcellular Localization and Role of Lipin-1 in Human Macrophages

(2011) M. Valdearcos et al.   JOURNAL OF IMMUNOLOGY

A novel human derived cell-penetrating peptide in drug delivery

(2010) Jian Zhao et al.   MOLECULAR BIOLOGY REPORTS

Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation

(2010) J.-M. Choi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

(2009) Frederic Heitz et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency

(2009) Falk Duchardt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein

(2009) Akiko Eguchi et al.   NATURE BIOTECHNOLOGY

Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis

(2008) J.-M. Choi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA